Vimarsana
Biggest News Aggregation in the World

Page 11 - Pharma Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Plc Today - Breaking & Trending Today

Poolbeg Pharma PLC Announces Results of Annual General Meeting - Vimarsana News

Poolbeg Pharma PLC Announces Results of Annual General Meeting

Poolbeg Pharma PLC Announces Results of Annual General Meeting

Destiny Pharma and SporeGen® announce update from research collaboration under Innovate UK grant award to develop a biotherapeutic treatment (SPOR-COV®) for COVID-19 and Influenza - Vimarsana News

Destiny Pharma and SporeGen® announce update from research collaboration under Innovate UK grant award to develop a biotherapeutic treatment (SPOR-COV®) for COVID-19 and Influenza

Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, today announces very encouraging results from its collaboration with SporeGen Limited ("SporeGen"), a UK biotechnology company working ...

Redx Pharma (LON:REDX) Shares Up 3.2% - Vimarsana News

Redx Pharma (LON:REDX) Shares Up 3.2%

Redx Pharma Plc (LON:REDX – Get Rating)’s stock price shot up 3.2% during trading on Friday . The stock traded as high as GBX 34.95 ($0.44) and last traded at GBX 32.50 ($0.41). 16,670 shares changed hands during trading, a decline of 2% from the average session volume of 16,956 shares. The stock had previously […]

N4 Pharma (LON:N4P) Stock Price Up 10.5% - Vimarsana News

N4 Pharma (LON:N4P) Stock Price Up 10.5%

N4 Pharma Plc (LON:N4P – Get Rating)’s share price traded up 10.5% on Tuesday . The company traded as high as GBX 2.29 ($0.03) and last traded at GBX 2.10 ($0.03). 5,110,068 shares were traded during trading, an increase of 697% from the average session volume of 641,109 shares. The stock had previously closed at […]

N4 Pharma testing to generate dose response curve for BCL-2 studies - Vimarsana News

N4 Pharma testing to generate dose response curve for BCL-2 studies

N4 Pharma testing to generate dose response curve for BCL-2 studies